Jim Alwan Appointed President and CEO of Ventec Life Systems

Jim Alwan will also serve as a member of the Ventec Board of Directors. Jim Alwan brings to Ventec Life Systems extensive medical device leadership experience with more than 25 years developing and managing healthcare products.

Most recently Alwan served as the Senior Vice President and General Manager of the Hospital Respiratory Care Business at Philips Healthcare and as the Vice President, Innovation and Business Development at Becton Dickinson. He has delivered innovation and profitable growth in functional and operational roles in the medtech, telecommunications, and semiconductor sectors throughout startup, mid-cap, and large-cap global corporations.

“Jim Alwan brings a track record of industry accomplishment and effective leadership to Ventec,” said Ventec Life Systems Board of Directors Chairman Jim Hickey. “He has a unique blend of market knowledge, general management, and engineering skills. We are pleased that Jim has joined Ventec and look forward to significant company growth under his guidance.”

“I am delighted to join Ventec Life Systems to expand upon the unprecedented growth and remarkable progress of this team,” said Alwan. “By re-imagining respiratory therapy delivery in a uniquely integrated and connected solution, they have unlocked value that is now reshaping the respiratory care market and improving the lives of patients and caregivers.”

In 2020, Ventec increased manufacturing production 80x to lead the response to the critical care ventilator demand from the U.S. Federal Government, state governments, hospital systems, long term care facilities, and homecare (DME) companies.

Ventec is building upon the award-winning innovation of the one-of-a-kind VOCSN Multi-Function Ventilator with revenue allocated for continued enhancements and the release of VOCSN Multi-View™ cellular, the first and only system to provide complete patient trending and monitoring for ventilator-dependent patients across multiple respiratory therapies.

Jim Alwan holds BS, MS, and PhD degrees in Electrical Engineering from the University of Illinois in Champaign-Urbana.

Hot this week

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.